Literature DB >> 1703482

Enhanced expression of insulin-like growth factor-binding protein-I in the fasted rat: the effects of insulin and growth hormone administration.

L J Murphy1, C Seneviratne, P Moreira, R E Reid.   

Abstract

The effect of fasting on insulin-like growth factor-binding protein-1 (IGFBP-1) expression was examined in the rat. Food deprivation for a period of 24 h resulted in a 9.5 +/- 2.0-fold increase in hepatic IGFBP-1 mRNA abundance (P less than 0.001). An increase in circulating IGFBP-1 in sera from fasted rats was demonstrated by immunoblotting, and an increased abundance of a 30-kDa IGFBP in sera from fasted rats was apparent when [125I]IGF-I was used in ligand blotting experiments. Refeeding resulted in a prompt decline in hepatic IGFBP-1 mRNA. Administration of insulin (0.5-4 U, ip) to fasted rats resulted in profound hypoglycemia, but either increased or had no significant effect on hepatic IGFBP-1 mRNA abundance. In contrast, administration of human GH (hGH; 100 micrograms, ip) resulted in a prompt decline in hepatic IGFBP-1 mRNA, followed by a late rebound in IGFBP-1 mRNA to levels greater than those in fasted controls. Furthermore, hepatic IGFBP-1 mRNA levels were significantly lower in hGH-treated (100 micrograms every 8 h) food-deprived rats than in saline-treated food-deprived rats (2.25 +/- 1.55- vs. 8.99 +/- 3.80-fold increase; P less than 0.005). Similar changes were observed when serum IGFBP-1 was quantitated by immunoblotting. The effects of GH could not be explained by secondary hyperinsulinism, since no significant increase in insulin levels was observed in GH-treated rats. From these observations we conclude the enhanced expression of IGFBP-1 in the food-deprived rat may be a consequence of GH deficiency rather than insulin deficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703482     DOI: 10.1210/endo-128-2-689

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

Review 1.  The role of insulin-like growth factor binding proteins in development.

Authors:  J M Pell; D A M Salih; L J Cobb; G Tripathi; A Drozd
Journal:  Rev Endocr Metab Disord       Date:  2005-08       Impact factor: 6.514

2.  Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice.

Authors:  K Rajkumar; M Krsek; S T Dheen; L J Murphy
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 3.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

4.  Comparative transcriptome profiles of large and small bodied large-scale loaches cultivated in paddy fields.

Authors:  Liulan Zhao; Kuo He; Qing Xiao; Qiao Liu; Wei Luo; Jie Luo; Hongmei Fu; Jiayao Li; Xugan Wu; Jun Du; Quan Gong; Xun Wang; Song Yang
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

5.  Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.

Authors:  Takeshi Inagaki; Vicky Y Lin; Regina Goetz; Moosa Mohammadi; David J Mangelsdorf; Steven A Kliewer
Journal:  Cell Metab       Date:  2008-07       Impact factor: 27.287

6.  Genome-wide analysis of FoxO1 binding in hepatic chromatin: potential involvement of FoxO1 in linking retinoid signaling to hepatic gluconeogenesis.

Authors:  Dong-Ju Shin; Pujan Joshi; Seung-Hyun Hong; Kathleen Mosure; Dong-Guk Shin; Timothy F Osborne
Journal:  Nucleic Acids Res       Date:  2012-10-12       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.